Clinical Trial Update: Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

View source ↗

Summary

A clinical trial update describes evaluating Sacituzumab Govitecan in Chinese patients with metastatic triple-negative breast cancer, focusing on real-world pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• TRODELVY (sacituzumab govitecan)

Snippet

Sponsor: Fudan University | Conditions: TNBC - Triple-Negative Breast Cancer | Status: NOT_YET_RECRUITING